SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-23-012744
Filing Date
2023-01-23
Accepted
2023-01-23 09:14:59
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d779598dsc14d9.htm SC 14D9 511092
2 EX-99.(E)(2) d779598dex99e2.htm EX-99.(E)(2) 73391
3 EX-99.(E)(7) d779598dex99e7.htm EX-99.(E)(7) 72132
4 EX-99.(E)(11) d779598dex99e11.htm EX-99.(E)(11) 24824
5 GRAPHIC g779598g83j19.jpg GRAPHIC 25641
  Complete submission text file 0001193125-23-012744.txt   718296
Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Filed by) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Subject) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-93228 | Film No.: 23542705
SIC: 2834 Pharmaceutical Preparations